Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A Journal Article

Authors: Detwiller, K. Y.; Fernando, N. T.; Segal, N. H.; Ryeom, S. W.; D'Amore, P. A.; Yoon, S. S.
Article Title: Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A
Abstract: Vascular endothelial cell growth factor A (VEGF-A) and hypoxia play important roles in tumor angiogenesis. VEGF-A gene expression is up-regulated in tumors under hypoxic conditions, yet it is unclear how such up-regulation will affect the efficacy of RNA interference strategies targeting VEGF-A. Four potential short interfering RNA (siRNA) sequences for the VEGF-A gene were cloned into expression plasmids and transfected into HT1080 human fibrosarcoma cells. Stable transfection of these plasmids decreased VEGF-A mRNA levels and protein secretion by up to 99%. Our analysis of >100 hypoxia-related genes using oligonucleotide microarrays of 38 human sarcoma samples and 14 normal tissues identified distinctly different patterns of expression between sarcomas and normal tissues as assessed by hierarchical clustering analysis. Numerous hypoxia-related genes were significantly up-regulated in sarcomas including hypoxia-inducible factor 1α (HIF-1α). Exposure of wild-type HT1080 cells to 1% hypoxia resulted in HIF-1α up-regulation and a 74% increase in VEGF-A secretion as compared with secretion under normoxic conditions. Surprisingly, stable cell lines expressing VEGF-A siRNAs silenced VEGF-A expression equally well in hypoxia and normoxia. S.c. injection of cells with VEGF-A siRNAs into athymic nude mice led to slower-growing tumors, decreased blood vessel density, and greater apoptosis when compared with controls. Immunofluorescence analysis of tumor sections revealed areas of HIF-1α nuclear expression, suggesting areas of hypoxia, in both control tumors and VEGF-suppressed tumors. We conclude that hypoxia plays an important role in human sarcomas but hypoxic up-regulation of VEGF-A expression does not attenuate the efficacy of VEGF-A RNA interference. ©2005 American Association for Cancer Research.
Keywords: controlled study; human tissue; vascular endothelial growth factor a; human cell; dna-binding proteins; nonhuman; mouse; animals; mice; apoptosis; gene expression; animal experiment; small interfering rna; rna, small interfering; rna interference; immunofluorescence; cell line, tumor; transfection; angiogenesis; neovascularization, pathologic; transcription factors; nuclear proteins; sarcoma; hypoxia; molecular cloning; gene expression regulation, neoplastic; fibrosarcoma; genetic transfection; mice, nude; oligonucleotide array sequence analysis; cell growth processes; vasculotropin a; plasmid; transplantation, heterologous; protein secretion; gene control; cell hypoxia; dna microarray; neoplasm transplantation; up-regulation; tumor vascularization; hypoxia inducible factor 1alpha; oligonucleotide; hypoxia-inducible factor 1, alpha subunit; hypoxia-inducible factor 1
Journal Title: Cancer Research
Volume: 65
Issue: 13
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2005-07-01
Start Page: 5881
End Page: 5889
Language: English
DOI: 10.1158/0008-5472.can-04-4078
PUBMED: 15994966
PROVIDER: scopus
Notes: --- - "Cited By (since 1996): 52" - "Export Date: 24 October 2012" - "CODEN: CNREA" - "Source: Scopus"
Citation Impact
MSK Authors
  1. Neil Howard Segal
    146 Segal